Incyte Says FDA Extended Review Period for Opzelura
click to rate
Posted by Two BlokesFri at 10:30 PM -
Filed in Stock
-
2 views
Incyte said federal regulators have extended the review period for evaluating its Opzelura cream as a treatment for moderate atopic dermatitis in children aged 2 to 11.